London, UK, July 9-13th, 2022 – Pushkang, the developer of technology and solutions of microfluidics, attented the International Society on Thrombosis and Haemostasis (ISTH) Congress. This international meeting attracts thousands of leaders in thrombosis, hemostasis and vascular biology. Highlights throughout the Congress will include more information on ground-breaking research, therapeutic solutions, and the newest clinical applications, which covered important topics such as COVID and blood clots, accquired bleeeding disoeders, women’s health, venous thromboembolism and more.
Pushkang will during the conference meet with all scientific advisers and representatives from all the professional fields to focus on reports, such as critical care and perioperative, acquired thrombocytopenias, VTE diagnosis and more. The discussions will touch on both new scientific advances in the field and the ongoing development of the company’s items of thrombus and hemostasis.
Pushkang, the only on-site exhibitor from china, showcased leading-edge Coagulation POCT solutions. With its reliable performance, easy-to-use design, and high efficiency, Pushkang’s coagulation analyzers captured countless visitors. Those who had intensed interests in applying Coagulation POCT devices to multiple scenarios as soon as possible.
By participating in the ISTH conference, Pushkang will communicate and cooperate with industry leaders, and strive to promote the development of microfluidic technology and blood coagulation POCT, so as to improve the global medical practice in the field of thrombosis and hemostasis, and provide patients with better diagnosis and treatment options .Staying true to the mission of “Accessible health testing at your side”, Pushkang will continue to its dedication to developing innovative solutions for the global human healthcare.
Post time: Jul-18-2022